On March 6th, 2020, Avivagen CEO Kym Anthony and Executive VP of Business Development and Product Innovation, James Nickerson, appeared on BioPub.  The interview was entitled “Avivagen: Farming for the Future”.

It’s like a domino – each time you get somebody new using the product it makes it easier in that market to use more and more. . . this is in fact in our view our inflection year, a year of dominoes falling. – Kym Anthony

From BioPub:
Avivagen is developing and commercializing products that promote health in animals and humans. The Corporation’s unique OxC-beta™ technology is a proprietary, first-in-class source of β-carotene-oxygen copolymer compounds that confer a variety of immune-supporting non-vitamin A benefits. These benefits have wide, global utility, including serving as an alternative to antibiotics in livestock feeds, as well as for food- production conditions where antibiotics cannot be used, and supporting good health in companion animals.

You can watch the webinar in its entirety here: